Dani, Zenaida B.
HRN: 25-88-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/20/2025
01/27/2025
IV
1.5
Q8
Infected Wound, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes